HETEROCYCLIC PPAR MODULATORS
    6.
    发明申请
    HETEROCYCLIC PPAR MODULATORS 审中-公开
    杂环PPAR调节剂

    公开(公告)号:WO2004063166A1

    公开(公告)日:2004-07-29

    申请号:PCT/US2003/039119

    申请日:2003-12-31

    Abstract: The present invention is directed to compounds represented by the following structural formula, Formula I: wherein: (a) X is selected from the group consisting of a single bond, O, S, S(O)2 and N; (b) U is an aliphatic linker; (c) Y is selected from the group consisting of O, C, S, NH and a single bond; (d) E is C(R3)(R4)A or A and wherein (i) A is selected from the group consisting of carboxyl, tetrazole, C1-C6 alkylnitrile, carboxamide, sulfonamide and acylsulfonamide; (e) Z1 and Z2 are each independently selected from the group consisting of N, O, and C with the proviso that at least one of Z1 and Z2 is N; (f) Z3 is selected from the group consisting of N, O, and C. (g) R8 is selected from the group consisting of hydrogen, C1-C6 alkyl, C1-C4 alkylenyl and halo; (h) R9 is selected from the group consisting of hydrogen, C1-C4 alkyl, C1-C4 alkylenyl, halo, aryl- C0-C4 alkyl, heteroaryl, C1-C6 allyl, and OR29.

    Abstract translation: 本发明涉及由以下结构式(I)表示的化合物:其中:(a)X选自单键,O,S,S(O)2和N; (b)U是脂族连接体; (c)Y选自O,C,S,NH和单键; (d)E是C(R3)(R4)A或A,其中(i)A选自羧基,四唑,C 1 -C 6烷基腈,甲酰胺,磺酰胺和酰基磺酰胺; (e)Z1和Z2各自独立地选自N,O和C,条件是Z1和Z2中的至少一个是N; (f)Z 3选自N,O和C.(g)R 8选自氢,C 1 -C 6烷基,C 1 -C 4亚烷基和卤素; (h)R 9选自氢,C 1 -C 4烷基,C 1 -C 4亚烷基,卤素,芳基-C 0 -C 4烷基,杂芳基,C 1 -C 6烯丙基和OR 29。

    PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR MODULATORS
    9.
    发明申请
    PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR MODULATORS 审中-公开
    过氧化物促进剂激活受体调节剂

    公开(公告)号:WO2008103574A3

    公开(公告)日:2008-12-18

    申请号:PCT/US2008053653

    申请日:2008-02-12

    CPC classification number: C07D401/06 C07D249/12

    Abstract: The present invention is directed to compounds of the structural Formula: wherein: R1 is H or -C1-C3 alkyl; R2 is selected from the group consisting of -H, -C1-C4 alkyl, -C1-C3 alkyl-CF3, phenyl, and pyridinyl; and R3 is selected from the group consisting of -H, -C1-C4 alkyl, -C1-C3 alkyl-O-CH3, -CH2-cyclopropyl, -CH2-C=CH2, -CH2CH2-(2-F-phenyl), and phenyl substituted with from 1 to 2 fluorines; provided that when R1 and R2 are each H, then R3 is selected from the group consisting of -C1-C4 alkyl, -C1-C3 alkyl-O-CH3, -CH2-cyclopropyl, -CH2-C=CH2, -CH2CH2-(2-F-phenyl), and phenyl substituted with from 1 to 2 fluorines; or stereoisomers and pharmaceutically acceptable salts thereof.

    Abstract translation: 本发明涉及结构式的化合物:其中:R 1是H或-C 1 -C 3烷基; R 2选自-H,-C 1 -C 4烷基,-C 1 -C 3烷基-CF 3,苯基和吡啶基; 并且R 3选自-H,-C 1 -C 4烷基,-C 1 -C 3烷基-O-CH 3,-CH 2 - 环丙基,-CH 2 -C = CH 2,-CH 2 CH 2 - (2-F-苯基) 和被1至2个氟取代的苯基; 条件是当R 1和R 2各自为H时,R 3选自-C 1 -C 4烷基,-C 1 -C 3烷基-O-CH 3,-CH 2 - 环丙基,-CH 2 -C = CH 2,-CH 2 CH 2 - (2-F-苯基)和被1至2个氟取代的苯基; 或其立体异构体及其药学上可接受的盐。

Patent Agency Ranking